Fate Therapeutics (FATE) Return on Sales (2012 - 2026)
Fate Therapeutics' (FATE) quarterly Return on Sales came in at 1.14% in Q1 2026, down 11.0% YoY from 1.28% in Q1 2025, and down 378.99% on a QoQ basis from 0.24% in Q4 2025.
Fate Therapeutics (FATE) Return on Sales (2012 - 2026) Analysis & Trends
Fate Therapeutics (FATE) has 14 years of Return on Sales data on file, last reported at 1.14% in Q1 2026.
- Quarterly Return on Sales fell 11.0% year-over-year to 1.14% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.48% (up 26.0% YoY) and the FY2025 annual result came in at 0.79%, down 38.0% from the prior year.
- Return on Sales declined to 1.14% in Q1 2026, from 0.24% in the prior quarter.
- In the past five years, Return on Sales ranged from a high of 0.02% in Q1 2023 to a low of 2.26% in Q4 2024.
- A 5-year average of 0.69% and a median of 0.43% in 2025 frame the typical range for Return on Sales.
- Annual changes were most pronounced in 2023 — Return on Sales slumped 211 bps — and 2025, when it surged 202 bps.
- Tracing FATE's Return on Sales over 5 years: stood at 0.08% in 2022, then plunged by 2619 bps to 2.19% in 2023, then declined by 3 bps to 2.26% in 2024, then jumped by 89 bps to 0.24% in 2025, then tumbled by 379 bps to 1.14% in 2026.
- The last three Return on Sales figures came in at 1.14% (Q1 2026), 0.24% (Q4 2025), and 0.43% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 0.00% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.00% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.00% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.00% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.00% |
| 10 | Fate Therapeutics | 298.82 Mn | 298.82 Mn | - | -1.14% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.14% |
| Dec 31, 2025 | -0.24% |
| Sep 30, 2025 | -0.43% |
| Jun 30, 2025 | -0.24% |
| Mar 31, 2025 | -1.03% |
| Dec 31, 2024 | -2.26% |
| Sep 30, 2024 | -0.65% |
| Jun 30, 2024 | -0.29% |
| Mar 31, 2024 | -0.54% |
| Dec 31, 2023 | -2.19% |
| Sep 30, 2023 | -1.10% |
| Jun 30, 2023 | -1.31% |
| Mar 31, 2023 | -0.02% |
| Dec 31, 2022 | -0.08% |
| Sep 30, 2022 | -0.10% |
| Jun 30, 2022 | -0.14% |
| Mar 31, 2022 | -0.05% |
| Dec 31, 2021 | -0.17% |
| Sep 30, 2021 | -0.17% |
| Jun 30, 2021 | -0.09% |